ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.

Spencer, AJ, Hill, F, Honeycutt, JD, et al.
2012

2

Journal article

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe, GM, Lorenzo, G, Lopez-Gil, E, et al.
2013

3

Journal article

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.

Spencer, AJ, Furze, J, Honeycutt, JD, et al.
2014-08-05

4

Journal article

A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report

Rampling, T, Ewer, K, Bowyer, G, et al.
2015-01-28

5

Journal article

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.

Antrobus, RD, Lillie, PJ, Berthoud, TK, et al.
2012

6

Journal article

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.

Ogwang, C, Afolabi, M, Kimani, D, et al.
2013

7

Journal article

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

Cottingham, MG, Andersen, RF, Spencer, AJ, et al.
2008

8

Journal article

Deletion of fifteen open reading frames from modified vaccinia virus Ankara fails to improve immunogenicity

Alharbi, NK, Spencer, AJ, Hill, AV, et al.
2015

9

Journal article

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.

Dicks, MD, Spencer, AJ, Edwards, NJ, et al.
2012

TO TOP